(VIANEWS) – Century Communities (CCS), TriCo Bancshares (TCBK), Novo Nordisk A/S (NVO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Century Communities (CCS)

28.4% sales growth and 33.68% return on equity

Century Communities, Inc., along with its affiliates, is involved in design, development, building, marketing, sales, and maintenance of single-family detached and attached homes.

Century Communities’s sales growth this year is expected to be 12.2% and 6.2% for next year.

Year-on-year quarterly revenue growth grew by 0.8%, now sitting on 4.22B for the twelve trailing months.

Volume

Today’s last reported volume for Century Communities is 281836 which is 37.74% below its average volume of 452677.

Century Communities’s sales growth for the next quarter is 28.4%. The company’s growth estimates for the ongoing quarter and the next is 31.1% and 45.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.68%.

Volatility

Century Communities’s last day, last week, and last month’s current intraday variation average was 0.15%, 2.07%, and 3.08%, respectively.

Century Communities’s highest amplitude of average volatility was 2.59% (day), 3.61% (last week), and 5.31% (last month), respectively.

Century Communities’s Stock Yearly Top and Bottom Value

Century Communities’s stock is valued at $54.45 at 16:22 EST, way under its 52-week high of $86.07 and way above its 52-week low of $46.63.

Century Communities’s Moving Average

Century Communities’s value is higher than its 50-day moving average of $52.98 and way under its 200-day moving average of $64.48.

2. TriCo Bancshares (TCBK)

19.3% sales growth and 10.18% return on equity

TriCo Bancshares is a holding company of Tri Counties Bank. It provides banking services for individual customers and corporations.

TriCo Bancshares’s sales growth this year is expected to be 14.2% and 11.1% for next year.

Year-on-year quarterly revenue growth declined by 14.8%, now sitting on 328.64M for the twelve trailing months.

Volume

Today’s last reported volume for TriCo Bancshares is 113373 which is 8.91% above its average volume of 104090.

TriCo Bancshares’s sales growth for the next quarter is 19.3%. The company’s growth estimates for the present quarter and the next is 4.3% and 13%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.18%.

Volatility

TriCo Bancshares’s last day, last week, and last month’s current intraday variation average was 1.00%, 1.39%, and 1.92%, respectively.

TriCo Bancshares’s highest amplitude of average volatility was 3.60% (day), 2.80% (last week), and 3.08% (last month), respectively.

TriCo Bancshares’s Stock Yearly Top and Bottom Value

TriCo Bancshares’s stock is valued at $42.54 at 16:22 EST, way under its 52-week high of $48.96 and way above its 52-week low of $37.41.

TriCo Bancshares’s Moving Average

TriCo Bancshares’s value is higher than its 50-day moving average of $40.59 and higher than its 200-day moving average of $42.40.

3. Novo Nordisk A/S (NVO)

11.2% sales growth and 70.63% return on equity

Novo Nordisk A/S is a global healthcare company that specializes in research, development and manufacture of pharmaceutical products.

Novo Nordisk A/S’s sales growth this year is anticipated to be 7.3% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.

Volume

Today’s last reported volume for Novo Nordisk A/S is 1009490 which is 33.43% below its average volume of 1516510.

Novo Nordisk A/S’s sales growth for the next quarter is 11.2%. The company’s growth estimates for the current quarter and the next is 6.9% and 12.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.63%.

Volatility

Novo Nordisk A/S’s last day, last week, and last month’s current intraday variation average was 0.23%, 0.60%, and 1.37%, respectively.

Novo Nordisk A/S’s highest amplitude of average volatility was 1.13% (day), 1.31% (last week), and 1.61% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $115.87 at 16:22 EST, below its 52-week high of $115.95 and way above its 52-week low of $66.59.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is above its 50-day moving average of $107.59 and way above its 200-day moving average of $90.32.

4. Enbridge (ENB)

10.7% sales growth and 9.89% return on equity

Enbridge Inc. is an American energy infrastructure company.

Enbridge’s sales growth this year is anticipated to be 5.3% and 0.7% for next year.

Year-on-year quarterly revenue growth grew by 25.1%, now sitting on 47.07B for the twelve trailing months.

Volume

Today’s last reported volume for Enbridge is 2382220 which is 39.91% below its average volume of 3964700.

Enbridge’s sales growth is a negative 0% for the ongoing quarter and 10.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 0% and 12.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.89%.

Volatility

Enbridge’s last day, last week, and last month’s current intraday variation average was 0.64%, 0.72%, and 0.84%, respectively.

Enbridge’s highest amplitude of average volatility was 0.75% (day), 1.62% (last week), and 1.68% (last month), respectively.

Enbridge’s Stock Yearly Top and Bottom Value

Enbridge’s stock is valued at $47.53 at 16:22 EST, above its 52-week high of $47.42.

Enbridge’s Moving Average

Enbridge’s value is higher than its 50-day moving average of $45.29 and way above its 200-day moving average of $41.98.

5. Shutterstock (SSTK)

8.9% sales growth and 20.1% return on equity

Shutterstock, Inc., is a technology company that provides content, tools, and services throughout North America, Europe, as well as internationally.

Shutterstock’s sales growth this year is expected to be 8.9% and 8.1% for next year.

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 789.27M for the twelve trailing months.

Volume

Today’s last reported volume for Shutterstock is 224585 which is 33.6% below its average volume of 338258.

Shutterstock’s sales growth for the next quarter is 8.9%. The company’s growth estimates for the present quarter and the next is a negative 8.8% and 24.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.1%.

Volatility

Shutterstock’s last day, last week, and last month’s current intraday variation average was 2.23%, 1.84%, and 2.49%, respectively.

Shutterstock’s highest amplitude of average volatility was 2.84% (day), 3.37% (last week), and 4.12% (last month), respectively.

Shutterstock’s Stock Yearly Top and Bottom Value

Shutterstock’s stock is valued at $59.55 at 16:22 EST, way under its 52-week high of $128.36 and above its 52-week low of $55.12.

Shutterstock’s Moving Average

Shutterstock’s value is way under its 50-day moving average of $74.29 and way under its 200-day moving average of $98.78.

LEAVE A REPLY

Please enter your comment!
Please enter your name here